- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials Sponsored by Zosano Pharma Corporation
Total 460 results
-
Zosano Pharma CorporationCompletedCluster HeadacheUnited States
-
Zosano Pharma CorporationCompleted
-
Zosano Pharma CorporationCompleted
-
Zosano Pharma CorporationCompleted
-
Zosano Pharma CorporationCompleted
-
Zosano Pharma CorporationCompletedMigraineUnited States
-
Zosano Pharma CorporationCompleted
-
Zosano Pharma CorporationCompletedPostmenopausal OsteoporosisUnited States
-
Zosano Pharma CorporationCompleted
-
Matrizyme Pharma CorporationCompletedChronic Coronary Total OcclusionsCanada, Israel, Netherlands
-
Jamp Pharma CorporationRecruitingRheumatoid Arthritis | Plaque Psoriasis | Crohn Disease | Ulcerative Colitis | Hidradenitis Suppurativa | Psoriatic Arthritis | Ankylosing SpondylitisCanada
-
Monash UniversityCaring Pharmacy; Bionime Corporation; Tigas PharmaActive, not recruiting
-
Mitsubishi Tanabe Pharma CorporationKureha CorporationCompletedChronic Kidney DiseaseUnited States, France, Italy, Ukraine, Argentina, Mexico, Poland, Canada, Brazil, Russian Federation, Czechia, Puerto Rico
-
Mitsubishi Tanabe Pharma CorporationKureha CorporationCompletedChronic Kidney DiseaseUnited States, Poland, Ukraine, Spain, Argentina, Mexico, Canada, Brazil, Russian Federation, Puerto Rico, Germany, Czechia
-
Mitsubishi Tanabe Pharma CorporationRecruiting
-
Orion Corporation, Orion PharmaActive, not recruitingProstate Cancer MetastaticFrance, United Kingdom, Finland, United States
-
Mitsubishi Tanabe Pharma CorporationCompletedJapanese Patients With ALSJapan
-
Mitsubishi Tanabe Pharma CorporationCompletedHealthy Adult SubjectsJapan
-
Mitsubishi Tanabe Pharma CorporationCompletedHealthy Adult SubjectsJapan
-
Mitsubishi Tanabe Pharma CorporationCompletedAnemia; Hemodialysis Dependent Chronic Kidney DiseaseJapan
-
Mitsubishi Tanabe Pharma CorporationCompleted
-
Mitsubishi Tanabe Pharma CorporationCompletedOsteoarthritis, Knee / Osteoarthritis, HipJapan
-
Mitsubishi Tanabe Pharma CorporationCompletedHealthy | Severe Hepatic ImpairmentCzechia, Hungary, Slovakia
-
Orion Corporation, Orion PharmaTerminatedAmyotrophic Lateral SclerosisCanada, United States, Australia, Germany, Belgium, Finland, Spain, Austria, Italy, France, Ireland, Netherlands, Sweden, United Kingdom
-
Mitsubishi Tanabe Pharma CorporationCompletedPainful Diabetic Peripheral NeuropathyJapan
-
Orion Corporation, Orion PharmaCompleted
-
Mitsubishi Tanabe Pharma CorporationCompletedType 2 Diabetes MellitusChina
-
Orion Corporation, Orion PharmaCompletedHealthy VolunteersFinland
-
Mitsubishi Tanabe Pharma CorporationCompleted
-
Mitsubishi Tanabe Pharma CorporationCompleted
-
Mitsubishi Tanabe Pharma CorporationCompleted
-
Orion Corporation, Orion PharmaCompletedSolid TumoursFrance, Finland, Spain, Italy, Denmark, United Kingdom
-
Mitsubishi Tanabe Pharma CorporationCompleted
-
Asahi Kasei Pharma CorporationCompleted
-
Orion Corporation, Orion PharmaCompletedCerumen Impaction of Both EarsLithuania
-
Asahi Kasei Pharma CorporationCompleted
-
Mitsubishi Tanabe Pharma CorporationCompletedAmyotrophic Lateral Sclerosis (ALS)Japan
-
Mitsubishi Tanabe Pharma CorporationCompletedType 2 Diabetes MellitusJapan
-
Mitsubishi Tanabe Pharma CorporationCompletedType 2 Diabetes MellitusJapan
-
Mitsubishi Tanabe Pharma CorporationCompletedAmyotrophic Lateral Sclerosis (ALS)Japan
-
Orion Corporation, Orion PharmaCompletedParkinson's DiseaseFinland, Germany, Hungary, Latvia
-
Mitsubishi Tanabe Pharma CorporationCompleted
-
Mitsubishi Tanabe Pharma CorporationCompletedAmyotrophic Lateral Sclerosis (ALS)
-
Orion Corporation, Orion PharmaCompletedAmyotrophic Lateral SclerosisIreland, Netherlands, United Kingdom, Germany
-
Orion Corporation, Orion PharmaCompleted
-
Orion Corporation, Orion PharmaCompleted
-
Mitsubishi Tanabe Pharma CorporationCompletedPlaque Psoriasis | Psoriatic Arthritis | Psoriatic Erythroderma | Pustular Psoriasis (Excluding a Localized)Japan
-
Orion Corporation, Orion PharmaCompleted
-
Mitsubishi Tanabe Pharma CorporationCompleted
-
Asahi Kasei Pharma CorporationCompletedDisseminated Intravascular CoagulationJapan